DeepMed Research

UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer

Phase 1

Completed

Conditions: Breast Cancer
Ovarian Cancer
Lung Cancer

First Posted Date: 2004-04-23

Last Posted Date: 2017-11-30

Lead Sponsor: University of Washington

Registration Number: NCT00005023

Locations: 🇺🇸
University of Washington School of Medicine, Seattle, Washington, United States

Indicated Prevention With At-Risk Gamblers

Phase 2

Completed

Conditions: Gambling
Pathological Gambling
Problem Gambling

Interventions: Behavioral: Personalized Feedback Intervention
Behavioral: Cognitive Behavioral Intervention

First Posted Date: 2004-02-24

Last Posted Date: 2013-12-11

Lead Sponsor: University of Washington

Target Recruit Count: 225

Registration Number: NCT00078273

Locations: 🇺🇸
University of Washington; Department of Psychiatry and Behavioral Sciences, Seattle, Washington, United States

Middle School to High School Transition Project: Depression and Substance Abuse Prevention

Phase 1

Completed

Conditions: Depression
Substance-Related Disorders

Interventions: Behavioral: Brief Intervention
Behavioral: CAST-T/HSTS

First Posted Date: 2003-10-28

Last Posted Date: 2016-08-17

Lead Sponsor: University of Washington

Target Recruit Count: 497

Registration Number: NCT00071513

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Role of Chronic Kidney Disease in Cardiovascular Disease

Withdrawn

Conditions: Heart Diseases
Cardiovascular Diseases
Kidney Failure, Chronic

First Posted Date: 2003-10-06

Last Posted Date: 2017-04-06

Lead Sponsor: University of Washington

Registration Number: NCT00069810

Caries Transmission Prevention in Alaska Native Infants

Phase 3

Terminated

Conditions: Dental Caries

Interventions: Drug: Chlorhexidine mouth rinse
Other: Xylitol chewing gum

First Posted Date: 2003-08-20

Last Posted Date: 2015-06-02

Lead Sponsor: University of Washington

Target Recruit Count: 250

Registration Number: NCT00067340

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Yakima Head Start Fluoride Varnish Study

Phase 3

Completed

Conditions: Dental Caries

First Posted Date: 2003-08-19

Last Posted Date: 2010-05-10

Lead Sponsor: University of Washington

Target Recruit Count: 500

Registration Number: NCT00067353

Locations: 🇺🇸
Enterprise for Progress in the Community (EPIC) Head Start sites, Lower Valley, Yakima County, Washington, United States
🇺🇸
Washington State Migrant Council Head Start sites, Lower Valley, Yakima County, Washington, United States

Early Orthodontic Intervention Under Medicaid

Phase 1

Conditions: Malocclusion

Interventions: Procedure: interceptive orthodontic treatments

First Posted Date: 2003-08-19

Last Posted Date: 2010-06-10

Lead Sponsor: University of Washington

Target Recruit Count: 150

Registration Number: NCT00067379

Locations: 🇺🇸
Odessa Brown Children's Clinic, Seattle, Washington, United States

Health Effects of Silver-Mercury Dental Fillings

Phase 3

Completed

Conditions: Caries, Dental

First Posted Date: 2003-08-05

Last Posted Date: 2018-06-04

Lead Sponsor: University of Washington

Target Recruit Count: 507

Registration Number: NCT00066118

Locations: 🇺🇸
University of Washington, School of Dentistry, Seattle, Washington, United States

Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver

Phase 2

Completed

Conditions: Colorectal Cancer
Metastatic Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2017-04-17

Lead Sponsor: University of Washington

Registration Number: NCT00030563

Locations: 🇺🇸
Ireland Cancer Center, Cleveland, Ohio, United States
🇺🇸
University of Washington School of Medicine, Seattle, Washington, United States
🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

Interleukin-2 in Treating Patients With Mycosis Fungoides

Phase 1

Completed

Conditions: Lymphoma

First Posted Date: 2003-01-27

Last Posted Date: 2012-12-04

Lead Sponsor: University of Washington

Target Recruit Count: 30

Registration Number: NCT00002687

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy